Protective vaccination against experimental canine visceral leishmaniasis using a combination of DNA and protein immunization with cysteine proteinases type I and II of L. infantum

Vaccine

Volumn 23, Issue 28, 2005, Pages 3716-3725

  Rafati, Sima ^a   Nakhaee, Alireza ^b   Taheri, Tahere ^a   Taslimi, Yasaman ^a   Darabi, Haideh ^a   Eravani, Davood ^a   Sanos, Stephanie ^c   Kaye, Paul ^c   Taghikhani, Mohammad ^a,b   Jamshidi, Shahram ^d   Rad, Mohammad Ali ^d  

^a PASTEUR INSTITUTE OF IRAN   (Iran)

^b TARBIAT MODARES UNIVERSITY   (Iran)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d UNIVERSITY OF TEHRAN   (Iran)

Author keywords

Canine visceral leishmaniasis; CpG ODN; Cysteine proteinases type I and II; Dog DNA vaccination

Indexed keywords

ADENOVIRUS VACCINE; ANTHELMINTIC AGENT; CANINE DISTEMPER MORBILLIVIRUS VACCINE; CPG OLIGODEOXYNUCLEOTIDE; CYSTEINE PROTEINASE; CYTOKINE; DNA VACCINE; GAMMA INTERFERON; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOLOGIC AGENT; INTERLEUKIN 10; KENNEL COUGH VACCINE; MESSENGER RNA; MONTANIDE; OLIGODEOXYNUCLEOTIDE DERIVATIVE; PARVOVIRUS VACCINE; T LYMPHOCYTE ANTIGEN; UNCLASSIFIED DRUG; VIRUS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW; CELL PROLIFERATION; CONTROLLED STUDY; DOG; IMMUNIZATION; LEISHMANIA INFANTUM; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; VISCERAL LEISHMANIASIS;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; BONE MARROW; CELL PROLIFERATION; CRICETINAE; CYSTEINE ENDOPEPTIDASES; CYTOKINES; DOGS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; IMMUNOGLOBULIN G; IRAN; LEISHMANIA INFANTUM; LEISHMANIASIS, VISCERAL; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTES; OLIGODEOXYRIBONUCLEOTIDES; RNA, MESSENGER; VACCINES, DNA; VACCINES, SUBUNIT;

EID: 21044441505     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.02.009     Document Type: Article

References (38)

1. World Health Organization. Tropical Disease Research Progress 1997-1998. Fourteen Programme Report. Geneva. Switzerland: UNDP/World Bank/Special Programme for Research and Training in Tropical Diseases (TDR), 1999, p. 1.
2. A. Nadim Present status of kala-azar in Iran Am J Trop Med Hyg 27 1978 25 28
3. D. Rioux, G. Lanotte, E. Serres, F. Prarlong, P. Bastien, and J. Prieres Taxonomy in Leishmania: use of isoenzymes. Suggestions for a new classification Ann Parasitol Hum Comp 65 1990 111 125
4. J. Alvar, C. Canavate, B. Gutierrez-solar, and M. Jimenez Leishmania and human immunodeficiency virus co-infection: the first 10 years Clin Microbiol Rev 10 1997 298 319
5. P. Abranches, M.C. Silva-Pereira, F.M. Conceicao-Silva, G.M. Santoa-Gomes, and J.G. Janz Canine leishmaniasis: pathology and ecological factors influencing transmission of infection J Parasitol 77 1991 557 561
6. C. Dye The logic of visceral leishmaniasis control Am J Trop Med Hyg 55 1996 125 130
7. A.S. Mazloumi, M.H. Hodjati, H. Mohite, and C.R. Davis Effect of insecticide impregnated dog collars on incidence of zoonotic visceral leishmaniasis in Iranian children: a matched cluster randomized trial Lancet 360 2002 374 379
8. S. Lasri, H. Sahibi, A. Sadak, C.L. Jaffe, and A. Rhalem Immune responses in vaccinated dogs with autoclaved Leishmania major promatigotes Vet Res 30 1999 441 449
9. W. Mayrink, O. Genaro, J.C. Franca-Silva, R.T. Costa, L. Tafuri, and V.P.C.P. Toledo Phase I and II open clinical trials of a vaccine against Leishmania chagasi infections in dogs Mem Inst Osw Cruz MEMIOC 91 1996 695 697
10. O. Genaro, J.A. Pinto, C.A. de Costa, J.C. Franca Silva, R.T. Costa, and J.C. Silva Phase III randomized double blind clinical trial of the efficacy of a vaccine against canine visceral leishmaniasis in urban area of Montes Claros, MG, Brazil Mem Inst Osw Cruz MEMIOC 91 1996 166
11. V.O. De Silva, G.P. Borja-Cabrera, N.N. Correia Pontes, E. Paraguai de Souza, K.G. Luz, and M. Palatnik A phase III trial of efficacy of the FML vaccine against canine kala-azar in an endemic area of Brazil (Sao Goncalo do Amarante, RN) Vaccine 19 2001 1082 1092
12. G.P. Borja-Cabrera, N.N. Correia Pontes, V.O. de Silva, E. Paraguai de Souza, W.R. Santos, and E.M. Gomes Long lasting protection against canine kala-azar using the FML-Quil A saponine vaccine un a endemic area of Brazil (Sao Goncalo do Amarante, RN) Vaccine 20 2002 3277 3284
13. J.C. Mottram, G.H. Coombs, and J. Alexander Cysteine peptidases as virulence factors of Leishmania Curr Opin Microbiol 7 2004 375 381
14. S. Rafati, S. Couty-Jouve, M.H. Alimohammadian, and J.A. Louis Biochemical analysis and immunogenicity of Leishmania major amastigote fraction in cutaneous leishmaniasis Clin Exp Immunol 110 1997 203 211
15. + T lymphocyte activation Vaccine 20 2002 2439 2447
16. S. Rafati, A. Salmanian, K. Hashemi, C. Schaff, S. Belli, and N. Fasel Identification of Leishmania major cysteine proteinases astargets of the immune response in human Mol Biochem Parasitol 113 2001 35 43
17. S. Rafati, A. Nakhaee, T. Tahere, A. Ghashghaii, A.H. Salmanian, and M. Jimenez Expression of cysteine proteinase type I and II of Leishmania infantum and their recognition by sera during canine and human visceral leishmaniasis Exp Parasitol 103 2003 143 151
18. M.L. Ortiz, M. Calero, C.F. Patron, L. Castellanos, and E. Mendez Imidazole-SDS-Zn reverse staining of proteins in gels containing or not SDS and microsequencing of individual unmodified electroblotted proteins FEBS Lett 296 1992 300 304
19. C. Chamizo, J.M. Rubio, J. Moreno, and J. Alvar Semi-quantitative analysis of multiple cytokines in canine peripheral blood mononuclear cells by a single tube RT-PCR Vet Immunol Immunopathol 83 2001 191 202
20. M.R. Rodgers, S.J. Poper, and D.F. Wirth Amplification of kinetoplast DNA as a tool in the detection and diagnosis of Leishmania Exp Parasitol 71 1990 267 275
21. K.J. Stacey, and J.M. Blackwell Immunostimulatory DNA as an adjuvant in vaccination against Leishmania major Infect Immun 67 1999 3719 3726
22. S. Gurunathan, D.L. Sacks, and D.R. Brown Vaccination with DNA encoding the immunodominant LACK parasite antigens confers protective immunity to mice infected with Leishmania major J Exp Med 186 1997 1137 1147
23. W.C. Lai, and M. Bennett DNA vaccines Crit Rev Immunol 18 1998 449 484
24. R.M. Gonzalo, G. Del Real, J.R. Rodriguez, D. Rodriguez, R. Heljasvaara, and P. Lucas A heterologous prime-boost regime using DNA and recombinant vaccinia virus expressing the Leishmania infantum p36/LACK antigen protects BALB/c mice from cutaneous leishmaniasis Vaccine 20 2002 1226 1231
25. K. Fragaki, I. Suffia, B. Ferrua, D. Rousseau, Fichoux Le, and J. Kubar Immunization with DNA encoding Leishmania infantum protein papLe22 decreases the frequency of parasitemic episodes in infected hamsters Vaccine 19 13/14 2001 1701 1709
26. R.T. Kenney, D.L. Sacks, A.A. Gam, H.W. Murray, and S. Uundar Splenic cytokine responses in Indian kala-azar before and after treatment J Infect Dis 177 1998 815 818
27. P. Abranches, G. Santos-Gomes, N. Rachamim, L.F. Schnur, and C.L. Jaffe An experimental model for canine visceral leishmaniasis Parasite Immunol 13 1991 537 550
28. E. Pinelli, R. Killick-Kendrick, J. Wagenaar, W. Bernadina, G. del Real, and J. Ruitenberg Cellular and humoral responses in dogs experimentally and naturally infected with Leishmania infantum Infect Immun 62 1994 229 235
29. E. Pinelli, R.M. Gonzalo, C.J. Boog, V.P. Rutten, D. Gebhard, and G. Del Real Leishmania infantum specific T cell lines derived from asymptomatic dogs that lyse infected macrophages in a major histocompatibility complex restricted manner Eur J Immunol 25 1995 1594 1600
30. G.M. Santos-Gomes, L. Campino, and P. Abranches Canine experimental infection: intradermal inoculation of Leishmania infantum promastigotes Mem Inst Oswaldo Cruz 95 2001 193 198
31. A.R. Nakhaee, T. Taheri, M. Taghikhani, M. Mohebali, A.H. Salmanian, and N. Fasel Humoral and cellular immune responses against Type I cysteine proteinase of Leishmania infantum are higher in asymptomatic than symptomatic dogs selected from a naturally infected population Vet Parasitol 119 2004 107 123
32. L. Lachaud, J. Dereure, E. Chabbert, J. Reynes, J.M. Mauboussin, and E. Oziol Optimized PCR using patient blood samples for diagnosis and follow-up of visceral leishmaniasis with special reference to AIDS patients J Clin Microbiol 38 2000 236 240
33. L. Cardoso, F. Neto, J.C. Sousa, M. Rodrigues, and M. Cabral Use of a leishmanin skin test in the detection of canine Leishmania-specific cellular immunity Vet Parasitol 79 1998 213 220
34. L. Solano-Gallego, J. Llull, G. Ramos, C. Riera, M. Arboix, and J. Alberola The Ibizian hound presents a predominantly cellular immune response against natural Leishmania infection Vet Parasitol 90 2000 37 45
35. L. Gradoni An update on anti-leishmanial vaccine candidates and prospects for a canine Leishmania vaccine Vet Parasitol 100 2001 87 103
36. J.R. Kirman, and R.A. Seder DNA vaccination: the answer to stable, protective T cell memory? Curr Opin Immunol 15 2003 471 476
37. S. Rafati, A.H. Salmanian, T. Taherei, M. Vafa, and N. Fasel A protective cocktail vaccine against murine cutaneous leishmaniasis with DNA encoding cysteine proteinases of Leishmania major Vaccine 19 2001 3369 3375
38. M.J. Ramiro, J. Zarate, T. Hanke, D. Rodriguez, J.R. Rodriguez, and M. Esteban Protection in dogs against visceral leishmaniasis caused by Leishmania infantum is achieved by immunization with a heterologous prime-boost regime using DNA and vaccinia recombinant vectors expression LACK Vaccine 21 2003 2474 2484